Combined treatment with BTX-A and ITB for spasticity: case report
- PMID: 17966716
Combined treatment with BTX-A and ITB for spasticity: case report
Abstract
One woman with profound mental retardation and spasticity living in a public residential developmental center was treated with intrathecal baclofen therapy and botulinum toxin type A injections. After one year of regular injections, extension across the right elbow increased 49 degrees. After one year of ITB, range of motion for left hip abduction increased 28 degrees; right hip abduction 9 degrees; left hip flexion 3 degrees; right hip flexion 1 degree; right knee flexion 31 degrees. Our case demonstrates the importance of a multidisciplinary approach in order to ease care and prevent complications. Expanded investigations should be carried out to evaluate the efficacy of combined therapy in patients with mental retardation.
Similar articles
-
Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.Mov Disord. 2010 Mar 15;25(4):466-73. doi: 10.1002/mds.22995. Mov Disord. 2010. PMID: 20131401
-
Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report.J Rehabil Med. 2010 Oct;42(9):891-4. doi: 10.2340/16501977-0596. J Rehabil Med. 2010. PMID: 20878052
-
Baclofen toxicity in an 8-year-old with an intrathecal baclofen pump.J Emerg Med. 2004 Feb;26(2):163-7. doi: 10.1016/j.jemermed.2003.07.009. J Emerg Med. 2004. PMID: 14980337
-
[Physical and other methods therapy of the spasticity in children].Przegl Lek. 2007;64(11):974-7. Przegl Lek. 2007. PMID: 18409416 Review. Polish.
-
[Botulinum toxin type A in the treatment plan for cerebral palsy].Wien Klin Wochenschr. 2001;113 Suppl 4:30-5. Wien Klin Wochenschr. 2001. PMID: 15506050 Review. German.